Source - LSE Regulatory
RNS Number : 7793Z
Probiotix Health PLC
08 August 2024
ProBiotix Health plc
("ProBiotix" or the "Company")
Result of AGM
ProBiotix Health plc (AQUIS: PBX), a life sciences business developing probiotics to support cardiometabolic health, announces that at the AGM held earlier today, all resolutions were duly passed.
The full voting results will be available on the website in due course here: https://probiotixhealth-ir.com/
For further information, please contact:
ProBiotix Health plc | |
Steen Andersen, Chief Executive | Contact via Walbrook below |
| |
Peterhouse Capital Ltd (Aquis Corporate Adviser and Broker) | Tel: 020 7469 0930 |
Mark Anwyl | |
Duncan Vasey | |
| |
Walbrook PR Ltd | probiotix@walbrookpr.com |
Anna Dunphy | Mob: 07876 741 001 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.